To evaluate how the inhibited expression of the protein could affect the ovarian cancer cell biology, Spry1 was initially silenced in 1A9 cells using the specific siRNA (Figure 3), with the protein expression being examined at 24, 48 and 72 hours post transfection (Figure 3A). The gene discussed is SPRY1; the disease is ovarian carcinoma.